Platelet Pl(A2) allele and incidence of coronary heart disease: Results from the atherosclerosis risk in communities (ARIC) study

Circulation

Volumn 102, Issue 16, 2000, Pages 1901-1905

  Aleksic, Nena ^a   Juneja, Harinder ^a   Folsom, Aaron R ^b   Ahn, Chul ^a   Boerwinkle, Eric ^c   Chambless, Lloyd E ^d   Wu, Kenneth K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d IL   (United States)

Author keywords

Coronary disease; Glycoproteins; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR; LEUCINE; PROLINE; RECEPTOR SUBTYPE; THROMBOCYTE PROTEIN PL A2; UNCLASSIFIED DRUG;

ADULT; ALLELISM; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE DISORDER;

EID: 0034680346     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.16.1901     Document Type: Article

References (26)

1. Platelet activation mechanisms and markers in arterial thrombosis
2. Prevention of myocardial infarction and stroke by aspirin: Different mechanisms? Different dosage?
3. The anti-GPIIb-IIIa agents: Fundamental and clinical aspects
4. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
5. Increased platelet aggregability associated with GPIIIa Pl(A2) polymorphism: The Framingham Offspring Study
6. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians
7. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
8. Platelet glycoprotein polymorphism and risk for coronary heart disease
9. Clues for understanding the structure and function of a prototypic human integrin: The platelet glycoprotein IIb/IIIa complex
10. Lack of association between platelet glycoprotein IIb/IIIa receptor Pl(A) polymorphism and coronary artery disease or carotid intima-media thickness
11. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young Central Europeans
12. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease
13. 33/Pro polymorphism (Pl(A1)/Pl(A2)) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM study
14. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives
15. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
16. Prospective study of coronary heart disease incidence in relation to fasting, total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) Study
17. ARIC Hemostasis Study-I: Development of blood collection and processing systems suitable for multicenter hemostatic studies
18. Correlation of specific platelet activation markers with carotid arterial wall thickness
19. Robust variance estimation for the case-cohort design
20. 2 polymorphism
21. Platelet glycoprotein IIIa Pl(A) polymorphism in young men with myocardial infarction
22. Platelet Pl(A) polymorphism, myocardial infarction, and extent of coronary artery disease
23. Pl(A1/A2) polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
24. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction
25. Platelet GP IIIa Pl(A) and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke
26. Higher prevalence of GPIIIa PLA2 polymorphism in siblings of patients with premature coronary heart disease